Lipopolysaccharide (LPS), purified from gram-negative bacteria, is well known to induce proinflammatory responses in monocytes and macrophages, and release of LPS from the microbial surface has been suggested to be an important initiating event in the sepsis syndrome. However, numerous studies have documented that a variety of constituents present in the outer cell membrane of gram-negative bacteria have the capacity to activate cells of the immune system. Given that the majority of immunotherapeutic approaches designed to intervene in gram-negative sepsis have to date targeted the LPS molecule, it would be of value to assess the relative proinflammatory properties of LPS and other gram-negative structures. Experiments were therefore undertaken to assess stimulation of human monocytes by components released from Escherichia coil following bacteriolysis by the cell wall-active antibiotic ceftazidime. As assessed by both induction of procoagulant activity and release of tumor necrosis factor, bacterial culture supernatants contain significant proinflammatory activity. When culture supernatants are fractionated via either velocity sedimentation in sucrose gradients or isopycnic density gradient ultracentrifugation in cesium chloride, the predominant monocyte-stimulating activity is identified in LPS-containing fractions. Further, such activity can be readily abrogated by the addition of polymyxin B. These results provide support for the hypothesis that LPS may be responsible for the majority of the proinflammatory activity released from E. coil following bacteriolysis in vitro.
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The systemic inflammatory response syndrome has recently been defined as a disease stemming from an uncontrolled proinflammatory response of the host immune system. While a variety of initiating stimuli have been associated with this syndrome, gram-negative microorganisms are often suggested as one of the leading causes of this disease. Cells of the monocyte/macrophage lineage have been strongly implicated as one of the major cellular effectors (11, 25) . There exists good correlative experimental evidence to suggest that lipopolysaccharide (LPS), a major component of the outer membrane of gram-negative microbes, may play an important role in the induction of the sepsis syndrome (22, 25) . Perhaps one of the stronger lines of evidence to support this concept are experiments in which administration of purified LPS to human volunteers or experimental animals faithfully reproduces many of the pathophysiological events classically seen in patients with gram-negative sepsis (5, 34) .
It has been established, however, that in addition to LPS, a variety of bacterial cell wall and/or outer membrane constituents, from both gram-negative and gram-positive bacteria, are also able to stimulate proinflammatory responses in cells of the immune system. In this respect, lipoprotein (10) , Helicobacter pylori water extract (19) , peptidoglycan (15) , lipid A-associated protein (21, 30) , and lipoteichoic acids (18) have all clearly been demonstrated to manifest proinflammatory activity in in vitro culture with human or murine immunologically relevant cells. Additionally, it has been recognized that treatment of bacteria with cell wall-active antibiotics can potentiate the release of microbial constituents, including LPS (7, 9, 17, 27) , which have the capacity to induce tumor necrosis factor (TNF) in whole blood ex vivo (4) and to cause lethality when administered to mice in vivo (7) . While it is reasonable to postulate that the presence of LPS in culture supernatants of gram-negative bacterial lysates would be sufficient to account for the observed biological activity, the potential presence of alternative bacterial constituents in addition to LPS, which might also manifest biological activity, would preclude absolute conclusions regarding the role of LPS. We have therefore designed studies to assess of 20 ,ug/ml (80 times the MIC) for 1.5 h to allow filamentation of the organisms, followed by 600 ,ug/ml (2,400 times the MIC) for 2.5 h to induce lysis of the bacteria. The cultures were then centrifuged at 3,000 rpm for 10 min at 5°C to remove particulate bacterial debris, and the culture supernatants were used for all subsequent experiments.
Colitose determination. LPS present in the lysates was quantitated by measurement of colitose (3,6-dideoxy-L-galactose), as described by Morrison and Leive (24) .
Isopycnic density gradient ultracentrifugation in cesium chloride. Cesium chloride density gradient ultracentrifugation was carried out essentially as described by Duncan and Morrison (8 ELISAs. Enzyme-linked immunosorbent assays (ELISAs) were used to detect the presence of LPS. These assays were carried out using experimental conditions previously established in our laboratory to provide optimal specific binding of antibody to LPS with minimal nonspecific binding (12) . In brief, Immulon 1 polystyrene microtiter plates (Fisher Scientific, St. Louis, Mo.) were treated with poly-L-lysine (average molecular weight, 80,000; Sigma Chemical Company) for 30 min at room temperature. The poly-L-lysine was then removed by "flicking" the plates, which were then coated with cesium chloride or sucrose gradient fractions containing antibiotictreated bacterial supernatants (see above) as the antigen at a dilution in phosphate-buffered saline (PBS, pH 7.4) of 1:5 for cesium chloride gradient fractions and 1:250 for sucrose gradient fractions. In preliminary experiments, these dilutions were found to provide optimal concentrations for antigen binding preparatory to addition of various antibodies. The plates were then incubated for 18 
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Induction of human monocytic proinflammatory responses by bacterial lysates. As an initial assessment of the ability of bacterial lysates to induce an LPS-dependent proinflammatory response in monocytes, antibiotic-treated bacterial lysates were prepared as described in Materials and Methods and compared with purified LPS for their ability to induce monocyte responses. The concentration of LPS in bacterial lysates was determined by a colitose assay, and equivalent concentrations of LPS, either in the lysate or in a chemically purified form, were assessed for the ability to induce PCA on monocytes. As shown by the data in Fig. 1 , the response of monocytes to LPS-containing bacterial lysates was superimposable with that of purified LPS in terms of threshold dose of stimulus required for activity as well as responsiveness to concentrations of LPS up to 0.5 ng/ml. Interestingly, monocyte responsiveness to purified LPS appeared to reach maximal levels near 0.5 ng of LPS per ml, while the response to the bacterial lysate continued to increase, reaching maximal stimulation with roughly 2 ng of LPS per ml. While there was a trend toward higher maximal PCA induction with bacterial lysate material than with purified LPS, the maximal response to these different preparations did not achieve statistical significance, as assessed by paired t tests. As also shown by the data in Fig. 1 , the addition of polymyxin B, an agent known to bind to the lipid A moiety of LPS and inhibit the biological effects of LPS (23) , resulted in an approximately 10-fold reduction in PCA-inducing activity in the bacterial lysate, suggesting that the majority of the stimulatory activity could be attributed to the presence of LPS. assess the relative stimulatory activity of LPS and other bacterial constituents present in bacterial lysates, samples were fractionated by ultracentrifugation in cesium chloride, which segregates individual constituents on the basis of partial specific volume, a procedure which readily separates protein and LPS. Following centrifugation, individual gradient fractions were assayed for the presence of LPS via ELISA and for protein via the Bradford assay. As shown by the data in Fig. 2 , the LPS fractionates as a relatively broad band in the middle of the gradient, with an approximate isopycnic density of 1.46 g/cm3. In contrast, proteins present in the bacterial lysates equilibrium band at a density of approximately 1.37 g/cm3. In control experiments, bacteria not subjected to antibiotic-induced bacteriolysis showed minimal release of LPS and protein (data not shown).
To assess the relative biological activity contained in the various fractions, fivefold serial dilutions were assayed for the capacity to induce PCA on freshly isolated human monocytes, and the dilution factor required to stimulate half-maximal activity was then calculated. The results of this analysis, shown in Fig. 2 , indicate that the majority of the monocyte-stimulatory activity is detected in those fractions with LPS, suggesting that LPS may be the dominant proinflammatory mediator found in bacterial lysates. Further evidence in support of this conclusion is provided by experiments with polymyxin B. As also shown by the data in Fig. 2, polymyxin PCA-inducing activity, monocytes were stimulated with fivefold serial dilutions of fractions in the presence (+PB) and absence (-PB) of 5 ,ug of polymyxin B per ml, and PCA was determined after 4 h. Data from duplicate cultures were used for PCA-inducing activity in the absence of polymyxin B; triplicate cultures were analyzed for PCAinducing activity in the presence of polymyxin B.
culture supernatant components; while this technique is effective in separating macromolecular constituents with differing partial specific volumes, it would not differentiate components having similar partial specific volumes. Velocity sedimentation, an alternative fractionation procedure which separates constituents based on mass, was therefore also carried out to fractionate bacterial lysates. As shown by the data in Fig. 3 , velocity sedimentation also effectively achieved separation of LPS and protein present in the bacterial lysates, with LPS sedimenting as a broad peak toward the bottom of the gradient. As was demonstrated earlier in the cesium chloride fractionation experiments, PCA-inducing activity was detected in those fractions containing the majority of the detectable LPS. Further, as shown by the data in Fig. 3 , induction of PCA present in the gradient fractions was abolished by the addition of polymyxin B.
Experiments were also carried out to assess whether results obtained with PCA would extend to other important mediators of the LPS-initiated inflammatory response, specifically, secretion of TNF. Representative fractions from the LPS-enriched bottom of the gradient (fractions 3 and 4), the proteinenriched middle of the gradient (fractions 14 and 16) , and the top of the gradient (fractions 22 and 24) were analyzed for their capacity to stimulate TNF release from human monocytes. As with PCA induction, various dilutions of these fractions were assayed, and the reciprocal of the dilution required to yield 400 U of TNF was then determined. The results of this experiment are summarized in Table 1 and indicate that the LPS-enriched gradient fractions were highly potent in eliciting TNF production by monocytes, and the bioactivity in these fractions was efficiently neutralized by polymyxin B. Less, but nevertheless significant, TNF-inducing activity was detected in the remaining fractions tested, and the activity in these fractions was less effectively neutralized by polymyxin B.
Since previous studies have shown that certain LPS-protein (25) , using components contained in gram-negative bacterial cell lysates. Two independent systems for fractionation of the supernatants of bacterial lysates, specifically, isopycnic fractionation and velocity sedimentation, effectively separated LPS constituents from the majority of the protein present in such lysates; further, in both systems, the fractions which contained the majority of the LPS also contained most of the monocytestimulatory activity. Inhibition studies with polymyxin B support the conclusion that a substantial component of PCA-and TNF-inducing activity found in lysate supernatants is likely to be LPS.
Given (2, 7, 9, 17, 33) . Hayes and Orr (16) have reported that relatively low concentrations of ceftazidime induce filamentation of E. coli, and the studies of Jackson and Kropp (17) correlate this with release of LPS. The initial addition of a subbactericidal concentration of ceftazidime to cultures in the experiments presented here was designed to allow such filamentation to occur. Clinically, suboptimal levels of antibiotics might be expected at the initiation of antibiotic therapy, because of the limitations of pharmacokinetics, and possibly during therapy, when trough levels occur between doses of the antibiotic. Hayes and Orr (16) have also shown that higher concentrations of ceftazidime result in rapid lysis of E. coli, and similar findings obtain in the studies reported in this paper, where higher concentrations of ceftazidime caused bacterial lysis and release of proteins and LPS. Other investigators have suggested the in vivo presence of such an LPS-releasing effect of antibiotics (28, 32, 33) , and our results indicate that this released LPS appears to be a potent, and predominant, stimulus of a monocytic proinflammatory response.
The significance of this release of LPS, however, within the overall complex series of pathophysiologic events occurring during sepsis, although queried by many investigators over the past several decades, has yet to be established unequivocally (1, 4, 14) . Thus, while pathophysiological changes following administration of antibiotics to patients with gram-negative infections have been reported in the medical literature by many investigators (3, 29) , there is no convincing evidence for a direct correlation between antibiotic-induced LPS release and adverse outcome. What is clear is that LPS released from the microbial surface is more biologically active than an equivalent amount of microbe-associated LPS (17a). Since our data reported here suggest that LPS contained in bacterial lysates is among the dominant microbial constituents capable of eliciting monocyte responses, these results would nevertheless be in accord with therapeutic strategies designed to target the LPS molecule in the treatment of gram-negative sepsis.
